Peter Greenleaf

Peter Greenleaf

Chief Executive Officer presso AURINIA PHARMACEUTICALS INC.

Patrimonio netto: 9 M $ in data 29/02/2024

54 anni
Health Technology
Commercial Services
Finance

Profilo

Peter S.
Greenleaf
is an American businessperson who has been at the head of 9 different companies.
Currently, he holds the position of Chairman for Revolo Biotherapeutics Ltd., President, Chief Executive Officer & Director at Aurinia Pharmaceuticals, Inc., Chairman for Maryland Venture Fund and Advisory at Petrichor Healthcare Capital Management LP.
Mr. Greenleaf is also on the board of Pharmaceutical Research & Manufacturers of America and ValenzaBio, Inc. In his past career Mr. Greenleaf was Director at Avalo Therapeutics, Inc., Principal at Hallmark Cards, Inc., Chairman for BioDelivery Sciences International, Inc., Chairman & Chief Executive Officer of Sucampo Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Histogenics Corp., President for MedImmune LLC, President of MedImmune Ventures, Inc., Vice President of Centocor, Inc., Principal at US Healthcare, Inc., Principal at Roche Diagnostics Corp.
and Director at Tech Council of Maryland, Inc. Mr. Greenleaf received an undergraduate degree from Western Connecticut State University and an MBA from St. Joseph's University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
06/03/2024 1 522 114 ( 1.05% ) 9 M $ 29/02/2024

Posizioni attive di Peter Greenleaf

SocietàPosizioneInizio
AURINIA PHARMACEUTICALS INC. Chief Executive Officer 29/04/2019
Consultant / Advisor -
Chairman 17/12/2020
Director/Board Member -
Chairman -
Director/Board Member -
Tutte le posizioni attive di Peter Greenleaf

Precedenti posizioni note di Peter Greenleaf

SocietàPosizioneFine
ANTARES PHARMA, INC. Director/Board Member 24/05/2022
BIODELIVERY SCIENCES INTERNATIONAL, INC. Chairman 22/03/2022
AVALO THERAPEUTICS, INC. Chief Executive Officer 15/04/2019
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Peter Greenleaf

Formazione di Peter Greenleaf

St. Joseph's University Masters Business Admin
Western Connecticut State University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Peter Greenleaf

Relazioni

99

Relazioni di 1° grado

31

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
KIORA PHARMACEUTICALS, INC.

Health Technology

AVALO THERAPEUTICS, INC.

Health Technology

AURINIA PHARMACEUTICALS INC.

Health Technology

SAVARA INC.

Health Technology

Aziende private25

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

LigoCyte Pharmaceuticals, Inc.

Health Technology

The University of Maryland Baltimore Foundation, Inc.

Miscellaneous

Finance

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Commercial Services

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Peter Greenleaf